San Fang Chemical Industry Co., Ltd. (TPE:1307)
30.70
-0.25 (-0.81%)
Aug 28, 2026, 1:30 PM CST
TPE:1307 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,073 | 10,815 | 10,780 | 10,087 | 10,763 | 8,384 | |
Revenue Growth | -0.10% | 0.33% | 6.87% | -6.29% | 28.38% | -0.68% |
Cost of Revenue | 7,592 | 7,393 | 7,481 | 7,561 | 9,029 | 6,871 |
Gross Profit | 3,480 | 3,422 | 3,299 | 2,526 | 1,734 | 1,513 |
Selling, General & Admin | 1,591 | 1,447 | 1,351 | 1,211 | 1,138 | 948.22 |
Research & Development | 438.26 | 421.7 | 387.78 | 330.39 | 301.38 | 294.5 |
Operating Expenses | 2,046 | 1,880 | 1,738 | 1,539 | 1,440 | 1,233 |
Operating Income | 1,434 | 1,542 | 1,560 | 987.08 | 294.29 | 279.4 |
Interest Expense | -84.77 | -81 | -75.4 | -73.79 | -56.46 | -48.15 |
Interest & Investment Income | 194.63 | 212.39 | 257 | 166.31 | 43.47 | 18.35 |
Currency Exchange Gain (Loss) | 232.43 | -179.53 | 242.25 | -6.73 | 319.9 | -86.52 |
Other Non Operating Income (Expenses) | 24.26 | 48.98 | 47.18 | 21.65 | 51.11 | 53.59 |
EBT Excluding Unusual Items | 1,800 | 1,543 | 2,031 | 1,095 | 652.3 | 216.68 |
Gain (Loss) on Sale of Investments | 12.44 | 0.88 | 9.6 | 6.27 | -8.35 | - |
Gain (Loss) on Sale of Assets | -0.67 | -5.54 | -5.72 | -3.94 | -84.54 | -0.11 |
Asset Writedown | -47.84 | -47.84 | -159.28 | -67.75 | - | - |
Other Unusual Items | 0.15 | - | - | - | - | -70.22 |
Pretax Income | 1,765 | 1,491 | 1,876 | 1,029 | 595.3 | 146.35 |
Income Tax Expense | 432.73 | 358.32 | 396.7 | 268.8 | 125.18 | 30.42 |
Net Income | 1,332 | 1,132 | 1,479 | 760.27 | 470.11 | 115.93 |
Net Income to Common | 1,332 | 1,132 | 1,479 | 760.27 | 470.11 | 115.93 |
Net Income Growth | 16.02% | -23.46% | 94.59% | 61.72% | 305.50% | -46.82% |
Shares Outstanding (Basic) | 398 | 398 | 398 | 398 | 398 | 398 |
Shares Outstanding (Diluted) | 399 | 399 | 400 | 399 | 399 | 398 |
Shares Change | -0.05% | -0.15% | 0.14% | 0.11% | 0.21% | -0.07% |
EPS (Basic) | 3.35 | 2.85 | 3.72 | 1.91 | 1.18 | 0.29 |
EPS (Diluted) | 3.34 | 2.84 | 3.70 | 1.90 | 1.18 | 0.29 |
EPS Growth | 16.28% | -23.24% | 94.74% | 61.02% | 306.90% | -47.08% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.45 | 710.12 | 1,338 | 1,498 | 1,022 | -755.46 |
Free Cash Flow Per Share | -0.01 | 1.78 | 3.35 | 3.75 | 2.56 | -1.90 |
Dividend Per Share | 2.200 | 2.200 | 2.700 | 1.500 | 0.800 | 0.500 |
Dividend Growth | -18.52% | -18.52% | 80.00% | 87.50% | 60.00% | 0% |
Gross Margin | 31.43% | 31.64% | 30.60% | 25.04% | 16.11% | 18.04% |
Operating Margin | 12.95% | 14.26% | 14.48% | 9.79% | 2.73% | 3.33% |
Profit Margin | 12.03% | 10.47% | 13.72% | 7.54% | 4.37% | 1.38% |
Free Cash Flow Margin | -0.03% | 6.57% | 12.41% | 14.85% | 9.49% | -9.01% |
EBITDA | 1,937 | 2,032 | 2,107 | 1,598 | 1,013 | 1,013 |
EBITDA Margin | 17.49% | 18.79% | 19.55% | 15.85% | 9.41% | 12.08% |
D&A For EBITDA | 503.18 | 490.03 | 546.78 | 611.25 | 718.9 | 733.27 |
EBIT | 1,434 | 1,542 | 1,560 | 987.08 | 294.29 | 279.4 |
EBIT Margin | 12.95% | 14.26% | 14.48% | 9.79% | 2.73% | 3.33% |
Effective Tax Rate | 24.52% | 24.04% | 21.14% | 26.12% | 21.03% | 20.78% |